Altogether, Latvia is planning to purchase 946 510 doses of vaccines from this producer.
For the purchase of vaccines, including logistical costs and administration, €14.4 million of emergency funding has been allocated.
Until now, Latvia had planned to purchase a dose of 300 000 vaccines from the manufacturer CureVac.
Health Minister Daniels Pavluts said after the government meeting that this decision strengthens our sense of safety that the Latvian people will have access to a sufficient and diverse portfolio of vaccines, which is important because "we cannot be sure that all deliveries will be timely."
The European Commission (EC) concluded an agreement with the vaccine producer CureVac earlier this week.